Abstract
Around 70% of men presenting with prostate cancer will have organ-confined disease, with the majority presenting with low- or intermediate-risk prostate cancer. This article reviews the evidence supporting the current standard of care in radiation oncology for the evaluation and management of men with intermediate-risk prostate cancer. Dose escalation, hormonal therapy, combined modality therapy, and modern techniques for the delivery of radiation therapy are reviewed.
Original language | English (US) |
---|---|
Pages (from-to) | 113-124 |
Number of pages | 12 |
Journal | Therapeutic Advances in Urology |
Volume | 4 |
Issue number | 3 |
DOIs | |
State | Published - Jun 2012 |
Keywords
- androgen deprivation
- brachytherapy
- dose escalation
- external beam
- intermediate risk
- outcomes
- prostate cancer
- radiation
- review
ASJC Scopus subject areas
- Urology